ST葫芦娃获得吸入用异丙托溴铵溶液药品注册证书

Core Viewpoint - ST HuLuWa (605199.SH) has received approval from the National Medical Products Administration for the registration of an inhalation solution containing ipratropium bromide, which will enhance the company's product line and positively impact its development [1] Group 1 - The company has obtained a drug registration certificate for the inhalation solution [1] - This new product is expected to enrich the company's product offerings [1] - The approval is seen as a positive development for the company's growth [1]